Developmental hemostasis: Pro- and anticoagulant systems during childhood

Seminars in Thrombosis and Hemostasis

Volumn 29, Issue 4, 2003, Pages 329-337

  Kuhle, Stefan ^a   Male, Christoph ^b   Mitchell, Lesley ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Children; Coagulation; Newborn; Review

Indexed keywords

ACTIVATED PROTEIN C; ALPHA 1 ANTITRYPSIN; ALPHA 2 MACROGLOBULIN; ANTICOAGULANT PROTEIN; ANTITHROMBIN; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; FIBRIN MONOMER; FIBRINOGEN; FIBRINOPEPTIDE A; FIBRINOPEPTIDE B; HEPARIN COFACTOR II; HIGH MOLECULAR WEIGHT KININOGEN; KININOGEN; PREKALLIKREIN; PROCOAGULANT; PROTEIN S; PROTHROMBIN; THROMBIN; THROMBIN ANTITHROMBIN COMPLEX; THROMBOPLASTIN; VON WILLEBRAND FACTOR;

AGE; BLEEDING; BLOOD CLOTTING DISORDER; CHILDHOOD DISEASE; FIBRIN CLOT; FIBRINOLYSIS; HEMOSTASIS; HUMAN; PARTIAL THROMBOPLASTIN TIME; PREMATURITY; PRIORITY JOURNAL; PROTHROMBIN TIME; REVIEW; THROMBIN TIME; THROMBOCYTE; THROMBOEMBOLISM;

AGE FACTORS; BLOOD COAGULATION; BLOOD COAGULATION FACTOR INHIBITORS; BLOOD COAGULATION FACTORS; BLOOD COAGULATION TESTS; CHILD; HEMATOPOIETIC SYSTEM; HEMOSTASIS; HUMANS; REFERENCE STANDARDS;

EID: 0041864034     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-42584     Document Type: Review

References (39)

1. Johnston M, Zipursky A. Microtechnology for the study of the blood coagulation system in newborn infants. Can J Med Tech 1980;42:159-164
2. Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the full-term infant. Blood 1987;70:165-172
3. Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the healthy premature infant. Blood 1988;72:1651-1657
4. Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L. Maturation of the hemostatic system during childhood. Blood 1992;80:1998-2005
5. Dahlbäck B. Blood coagulation. Lancet 2000;355:1627-1632
6. Cade JF, Hirsh J, Martin M. Placental barrier to coagulation factors: its relevance to the coagulation defect at birth and to haemorrhage in the newborn. Br Med J 1969;2:281-283
7. 2-macroglobulin, and prealbumin in the human conceptus. J Clin Invest 1969;48:1433-1446
8. Zilliacus H, Ottelin AM, Mattsson T. Blood clotting and fibrinolysis in human foetuses. Biol Neonat 1966;10:108-112
9. Reverdiau-Moalic P, Delahousse B, Body G, Bardos P, Leroy J, Gruel Y. Evolution of blood coagulation activators and inhibitors in the healthy human fetus. Blood 1996;88:900-906
10. Mazurier C, Daffos F, Forestier F. Electrophoretic and functional characteristics of the von Willebrand factor in human fetal plasma. Br J Haematol 1992;81:263-270
11. Weinstein MJ, Blanchard R, Moake JL, Vosburgh E, Moise K. Fetal and neonatal von Willebrand factor (vWF) is unusually large and similar to the vWF in patients with thrombotic thrombocytopenic purpura. Br J Haematol 1989;72:68-72
12. Katz JA, Moake JL, McPherson PD, et al. Relationship between human development and disappearance of unusually large von Willebrand factor multimers from plasma. Blood 1989;73:1851-1858
13. Thomas KB, Sutor AH, Altinkaya N, Grohmann A, Zehenter A, Leititis JU. von Willebrand factor-collagen binding activity is increased in newborns and infants. Acta Paediatr 1995;84:697-699
14. Witt I, Muller H, Künzer W. Evidence for the existence of foetal fibrinogen. Thromb Diath Haemorrhag 1969;22:101-109
15. Francis JL, Armstrong DJ. Sialic acid and enzymatic desialation of cord blood fibrinogen. Haemostasis 1982;11:223-228
16. Hassan HJ, Leonardi A, Chelucci C, et al. Blood coagulation factors in human embryonic-fetal development: preferential expression of the FVII/tissue factor pathway. Blood 1990;76:1158-1164
17. Karpatkin M, Blei F, Hurlet A, Greco A, Tang Z. Prothrombin expression in the adult and fetal rabbit liver. Pediatr Res 1991;30:266-269
18. Karpatkin M, Lee M, Cohen L, McKinnell J, Nardi M. Synthesis of coagulation proteins in the fetus and neonate. J Pediatr Hematol Oncol 2000;22:276-280
19. Holmberg L, Henriksson P, Ekelund H, Åstedt B. Coagulation in the human fetus. Comparison with term newborn infants. J Pediatr 1974;85:860-864
20. Kisker CT, Robillard JE, Clarke WR. Development of blood coagulation - a fetal lamb model. Pediatr Res 1981;15:1045-1050
21. Andrew M, O'Brodovich H, Mitchell L. Fetal lamb coagulation system during normal birth. Am J Hematol 1988;28:116-118
22. McDonald MM, Hathaway WE, Reeve EB, Leonard BD. Biochemical and functional study of antithrombin III in new-born infants. Thromb Haemost 1982;47:56-58
23. 2-macroglobulin is an important progressive inhibitor of thrombin in neonatal and infant plasma. Thromb Haemost 1989;62:1074-1077
24. 2-macroglobulin and antithrombin on thrombin generation and inhibition in cord and adult plasma. Thromb Res 2001;101:183-191
25. Andrew M, Mitchell L, Berry L, et al. An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant woman and her fetus. J Clin Invest 1992;89:321-326
26. Petäjä J, Fernandez JA, Fellman V, Griffin JH. Upregulation of the antithrombotic protein C pathway at birth. Pediatr Hematol Oncol 1998;15:489-499
27. Suarez CR, Menendez CE, Walenga JM, Fareed J. Neonatal and maternal hemostasis: value of molecular markers in the assessment of hemostatic status. Semin Thromb Hemost 1984;10:280-284
28. Yuen PM, Yin JA, Lao TT. Fibrinopeptide A levels in maternal and newborn plasma. Eur J Obstet Gynecol Reprod Biol 1989;30:239-244
29. Greffe BS, Marlar RA, Manco-Johnson MJ. Neonatal protein C: molecular composition and distribution in normal term infants. Thromb Res 1989;56:91-98
30. Schwarz HP, Muntean W, Watzke H, Richter B, Griffin JH. Low total protein S antigen but high protein S activity due to decreased C4b-binding protein in neonates. Blood 1988;71:562-565
31. Menashi S, Aurousseau MH, Gozin D, et al. High levels of circulating thrombomodulin in human foetuses and children. Thromb Haemost 1999;81:906-909
32. Weissbach G, Harenberg J, Wendisch J, Pargac N, Thomas K. Tissue factor pathway inhibitor in infants and children. Thromb Res 1994;73:441-446
33. Patel P, Weitz J, Brooker LA, Paes B, Mitchell L, Andrew M. Decreased thrombin activity of fibrin clots prepared in cord plasma compared with adult plasma. Pediatr Res 1996;39:826-830
34. Schmidt B, Ofosu FA, Mitchell L, Brooker LA, Andrew M. Anticoagulant effects of heparin in neonatal plasma. Pediatr Res 1989;25:405-408
35. Andrew M, Mitchell L, Vegh P, Ofosu F. Thrombin regulation in children differs from adults in the absence and presence of heparin. Thromb Haemost 1994;72:836-842
36. Chan AK, Berry LR, Monagle PT, Andrew M. Decreased concentrations of heparinoids are required to inhibit thrombin generation in plasma from newborns and children compared to plasma from adults due to reduced thrombin potential. Thromb Haemost 2002;87:606-613
37. Cvirn G, Gallistl S, Leschnik B, Muntean W. Low tissue factor pathway inhibitor (TFPI) together with low antithrombin allows sufficient thrombin generation in neonates. J Thromb Haemost 2003;1:263-268
38. Knöfler R, Hofmann S, Weissbach G, et al. Molecular markers of the endothelium, the coagulation, and the fibrinolytic systems in healthy newborns. Semin Thromb Hemost 1998;24:453-461
39. Ries M, Klinge J, Rauch R. Age-related reference values for activation markers of the coagulation and fibrinolytic systems in children. Thromb Res 1997;85:341-344